NEW DELHI -- India is stepping up defenses against a possible third wave of coronavirus infections caused by omicron by implementing a slew of measures, including approving two more vaccines as well as Merck's COVID-19 pill, and expanding its inoculation drive to those aged 15 to 18.
COVID vaccines
India approves 2 more COVID vaccines, Merck's antiviral drug
Inoculation to be expanded to 15-18 age group in anticipation of omicron wave
India has approved molnupiravir to treat adult patients. © Reuters
Read Next
Latest on COVID vaccines
